GlassScriptPhysician profile
Brian D Forbus
NPI 1225103302
$2,141.36
in general payments reported to CMS, 2019-2025
22 companies · $572 in 2025
The $572 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $376 · 2022: $335 · 2023: $358 · 2024: $500 · 2025: $572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,430.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $537.75 | 2021-2025 | General - Therapies, General - Pain Management, Wavewriter Alpha Prime 16 |
| Astrazeneca Pharmaceuticals LP | $214.88 | 2021-2025 | Farxiga, Airsupra |
| Vertos Medical, INC. | $145.06 | 2021-2023 | Mild Device Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $140.99 | 2023-2025 | Trintellix |
| Amgen INC. | $118.25 | 2023-2025 | Otezla, Repatha, Repatha |
| Abbvie INC. | $112.44 | 2023-2025 | |
| Phathom Pharmaceuticals, INC. | $111.17 | 2024 | Voquezna |
| Medtronic, INC. | $99.46 | 2023-2024 | Kyphon Express II Kyphopak Tray, Osteocool Rf Ablation System |
| Relievant Medsystems, INC. | $90.14 | 2022-2023 | Intracept |
| Si-Bone, INC. | $85.20 | 2022-2025 | |
| Saluda Medical Americas, INC. | $84.24 | 2024-2025 | Evoke |
| Pfizer INC. | $75.19 | 2024-2025 | |
| Novo Nordisk INC | $63.89 | 2021-2025 | Rybelsus, Ozempic |
| Spinal Simplicity, LLC | $59.15 | 2022-2025 | Ha Minuteman G3-R |
| Abbott Laboratories | $44.62 | 2021-2023 | Quantisal |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $34.94 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $33.64 | 2024-2025 | Trelegy Ellipta |
| Lilly USA, LLC | $29.43 | 2024-2025 | Mounjaro, Zepbound |
| Otsuka America Pharmaceutical, INC. | $15.82 | 2024 | Rexulti |
| Collegium Pharmaceutical, INC. | $15.45 | 2021 | |
| Forte Bio-Pharma LLC | $15.36 | 2021 | |
| Biodelivery Sciences International, INC. | $14.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Forbus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.